Medical Pharmacology: Chapter 15: Local Anesthetic Pharmacology -- Module 5: Neuraxial Anesthesia

Chapter 15: Local Anesthetic Pharmacology — Module 5: Neuraxial Anesthesia
Conceptual Understanding (13 questions)

1. An elderly patient with significant aortic stenosis requires anorectal surgery. The anesthesiologist wants surgical anesthesia of the perineum while minimizing the abrupt sympathectomy that a higher block would impose on a preload-dependent heart. Integrating baricity, patient position, and dose, which plan best achieves both goals?

A) A large dose of hyperbaric bupivacaine with the patient supine and placed head-down, to ensure a high reliable block
B) A standard surgical dose of isobaric bupivacaine with the patient supine, accepting whatever level results
C) A small dose of hyperbaric bupivacaine with the patient kept sitting for several minutes, so the dense solution settles into the lumbosacral segments and produces a saddle block that largely spares the higher sympathetic fibers
D) A large dose of hypobaric solution with the patient sitting, so the drug rises to the thoracic segments
E) Any large-volume epidural bolus, since volume alone determines whether the block stays low

ANSWER: C

Rationale:

The plan must combine three principles at once. A small dose limits the total mass available to spread; a hyperbaric solution sinks under gravity; and keeping the patient sitting makes the lumbosacral region the dependent zone, so the dense drug pools there. Together these confine a saddle block to the sacral roots, giving perineal surgical anesthesia while sparing the higher thoracic sympathetic fibers whose blockade would cause the abrupt vasodilation and preload loss that a preload-dependent, aortic-stenosis heart tolerates poorly.

Option A: Option A combines a large dose, hyperbaric solution, and head-down position, all of which drive the block high, producing exactly the extensive sympathectomy to be avoided.
Option B: Option B abandons control of level by using an isobaric solution supine at a full surgical dose, risking an unnecessarily high block.
Option D: Option D uses a hypobaric solution to drive the block cephalad, the opposite of the goal.
Option E: Option E misapplies the volume-spread idea to a setting where the aim is a low, dense, controlled block, and a large epidural bolus would broaden rather than confine the block.

2. A 78-year-old obese patient is scheduled for spinal anesthesia. A colleague proposes the same hyperbaric bupivacaine dose he routinely uses for young, average-build patients. Integrating the determinants of block level with this patient's physiology, what should you predict and recommend?

A) The standard dose will likely produce a higher-than-intended block, because both advanced age and obesity reduce effective CSF volume so the same mass of drug spreads over more segments; the dose should be reduced
B) The standard dose will produce a lower-than-intended block, because elderly obese patients have expanded CSF volume that dilutes the drug; the dose should be increased
C) The dose is irrelevant because block level in spinal anesthesia is set entirely by injection speed
D) The standard dose is appropriate without change, because age and body habitus have no influence on spinal spread
E) A larger dose is needed because obesity creates a pharmacologic barrier that prevents intrathecal drug from reaching the nerve roots

ANSWER: A

Rationale:

This requires combining the rule that block level tracks the mass of drug relative to the CSF compartment with the patient factors that shrink that compartment. Advanced age narrows the subarachnoid space, and obesity raises intra-abdominal pressure transmitted to the epidural space, engorging epidural veins and reducing effective CSF volume; both mean a given mass spreads farther and produces a higher block. The correct response is to anticipate overshoot and reduce the dose. Option C wrongly attributes block level to injection speed, ignoring mass and CSF volume. Option D denies well-established patient-factor effects on spread.

Option B: Option B inverts the physiology by claiming expanded CSF volume in this group.
Option E: Option E fabricates a diffusion barrier from obesity; the relevant effect is reduced CSF volume, which raises rather than blocks the level.

3. You must select a spinal agent for two different cases on the same list: Case 1 is a procedure of uncertain, possibly long duration; Case 2 is a fixed 40-minute ambulatory procedure with same-day discharge. Integrating how lipid solubility governs clearance from CSF with each case's duration goal, which selection is most rational?

A) Use preservative-free chloroprocaine for both cases, because rapid clearance is always preferable
B) Use hyperbaric bupivacaine for both cases, because a single dense agent simplifies practice regardless of duration
C) Use chloroprocaine for Case 1 and hyperbaric bupivacaine for Case 2, matching the short agent to the long case
D) Use a lipophilic long-acting agent such as hyperbaric bupivacaine for Case 1, whose vascular-uptake clearance gives a long, dense block suited to an uncertain duration, and preservative-free chloroprocaine for Case 2, whose rapid clearance allows quick recovery and discharge
E) Duration cannot be influenced by agent choice, so either agent works equally well for both cases

ANSWER: D

Rationale:

The decision requires linking clearance mechanism to the duration each case demands. Lipophilic agents such as bupivacaine are cleared from CSF chiefly by slow vascular uptake into cord tissue, giving a long, dense block well matched to a procedure of uncertain or potentially long duration. Chloroprocaine is cleared rapidly and has a short, predictable duration with quick recovery, which is exactly what a fixed brief ambulatory case needs for same-day discharge. Pairing the long agent to the long case and the short agent to the short case is the rational plan. Option E denies the well-established link between agent choice and block duration.

Option A: Option A ignores Case 1's need for sustained block.
Option B: Option B ignores Case 2's need for rapid recovery and would delay discharge.
Option C: Option C reverses the correct pairing, giving the short agent to the long case.

4. A laboring patient receiving an oxytocin infusion is to have an epidural test dose. Integrating how the epinephrine marker works with the cardiovascular physiology of labor, why is interpretation difficult here, and how should you proceed?

A) The epinephrine marker is more reliable in labor because contractions amplify the heart rate response, so any value can be trusted
B) Uterine contractions, augmented by oxytocin, produce transient maternal tachycardia that can mimic or obscure the epinephrine-induced heart rate rise; the test should be given during a quiescent inter-contraction interval with the immediate pre-injection baseline documented
C) Oxytocin chemically neutralizes the epinephrine, so the marker is permanently absent and the test should be skipped
D) Labor abolishes the lidocaine motor-block marker, so intrathecal placement can no longer be detected by any means
E) The test dose is unnecessary in laboring patients because epidural catheters are never intravascular during labor

ANSWER: B

Rationale:

This integrates the mechanism of the epinephrine marker with labor physiology. The marker relies on detecting a discrete epinephrine-driven rise in heart rate; but contractions, intensified by an oxytocin infusion, themselves cause transient maternal tachycardia that can be mistaken for, or can mask, a positive response. The correct approach is to inject during a quiescent interval between contractions and to document the immediate pre-injection baseline so a true epinephrine response can be distinguished from contraction-related tachycardia. Option E is unsafe and false, since intravascular catheter placement remains a real risk in labor.

Option A: Option A inverts the problem; contraction-related tachycardia reduces, not improves, reliability.
Option C: Option C fabricates chemical neutralization of epinephrine by oxytocin.
Option D: Option D is incorrect because the lidocaine motor-block marker for intrathecal placement remains usable.

5. A patient on chronic beta-blocker therapy receives an epidural test dose, and the heart rate does not change. Integrating the limitation of the epinephrine marker in beta-blockade with the need to exclude intravascular placement, how should you interpret and act on this result?

A) A flat heart rate definitively confirms correct epidural placement, so proceed with the full dose immediately
B) A flat heart rate proves intrathecal placement, so remove the catheter at once
C) The beta-blocker has no effect on the marker, so the flat response can be interpreted exactly as in any other patient
D) The full therapeutic dose should be given rapidly to force a clearer response if the catheter is intravascular
E) Because beta-blockade blunts the chronotropic response, a flat heart rate cannot exclude intravascular placement; you must look for alternative signs such as a rise in blood pressure, palpitations, or T-wave changes on continuous ECG, and aspirate and dose cautiously in fractionated increments

ANSWER: E

Rationale:

This combines the specific failure of the epinephrine marker under beta-blockade with the reasoning needed to stay safe. Because a beta-blocker blunts or abolishes the heart rate rise that the marker depends on, an unchanged heart rate is uninformative and cannot rule out intravascular placement. The clinician must therefore seek alternative markers of intravascular injection (a rise in blood pressure, palpitations, or T-wave changes on continuous ECG) and dose cautiously in fractionated increments with aspiration rather than trusting the negative heart rate response. Option A is dangerous because it treats an uninterpretable result as reassuring. Option D is hazardous because rapidly giving the full dose to provoke a response risks systemic toxicity or total spinal if the catheter is misplaced.

Option B: Option B is incorrect because a flat heart rate does not indicate intrathecal placement, which is signaled instead by motor block.
Option C: Option C ignores the established effect of beta-blockade on the marker.

6. You are designing a postoperative thoracic epidural infusion after an open upper-abdominal operation. The goal is analgesia covering the incisional dermatomes while preserving lower-extremity strength so the patient can mobilize. Integrating how concentration governs block density with how volume governs segmental spread, which solution strategy best meets both goals?

A) A low (dilute) local anesthetic concentration, typically combined with a low-dose opioid, delivered at a volume and rate sufficient to cover the incisional segments, so analgesia is achieved across the needed dermatomes while motor fibers are largely spared
B) A high local anesthetic concentration at a low volume, to guarantee dense block confined to a single segment
C) A high concentration at a high volume, to maximize both density and spread regardless of motor effect
D) Concentration and volume are interchangeable, so any combination giving the same total milligrams produces the same clinical result
E) An opioid-only infusion with no local anesthetic, since local anesthetics cannot contribute to epidural analgesia

ANSWER: A

Rationale:

Meeting both goals requires using concentration and volume for their separate jobs. A low concentration produces predominantly sensory analgesia while sparing motor fibers, preserving the leg strength needed for mobilization; an adequate volume and rate spread that dilute solution across the several incisional dermatomes that need coverage. Adding a low-dose opioid exploits epidural local-anesthetic-opioid synergy to deepen analgesia without raising motor block. Option B confines the block to too few segments and, at high concentration, produces unwanted motor block. Option C maximizes density and spread but causes dense motor block, defeating the mobilization goal. Option E discards the local anesthetic contribution, ignoring the synergy that allows effective analgesia at low drug exposure.

Option D: Option D is incorrect because concentration and volume are not interchangeable; they control density and spread respectively.

7. A term parturient develops rapid, profound hypotension within minutes of a spinal for cesarean delivery, more severe than you would expect in a non-pregnant patient. Integrating the sympathectomy of neuraxial block with the cardiovascular physiology of pregnancy, which explanation and management approach is most accurate?

A) The hypotension is mild and slow in pregnancy, so no vasopressor is needed and only slow fluid loading is appropriate
B) Pregnancy increases sympathetic vasomotor reserve, so the block's effect is blunted and ephedrine is contraindicated
C) Baseline progesterone-mediated vasodilation leaves less vasomotor reserve to lose, and aortocaval compression by the uterus preferentially reduces uteroplacental flow, so the sympathectomy produces faster, deeper hypotension; management combines left uterine displacement with phenylephrine, which best preserves uteroplacental perfusion
D) The cause is purely mechanical airway obstruction, so vasopressors are irrelevant and intubation alone corrects the pressure
E) Phenylephrine must be avoided because its alpha effect dangerously reduces placental perfusion; only beta-agonists are safe in obstetrics

ANSWER: C

Rationale:

This requires layering three ideas. Neuraxial block causes sympathectomy and vasodilation; pregnancy already lowers vascular tone through progesterone-mediated vasodilation, so there is less reserve to lose; and the gravid uterus compresses the aorta and inferior vena cava, so any fall in pressure preferentially compromises uteroplacental flow. Together these make obstetric spinal hypotension faster and deeper, and management pairs left uterine displacement with phenylephrine, the vasopressor shown to best preserve uteroplacental perfusion. Option E contradicts the evidence, which supports phenylephrine as preserving rather than reducing uteroplacental flow.

Option A: Option A understates the severity and omits needed treatment.
Option B: Option B inverts the reserve physiology and wrongly bars ephedrine.
Option D: Option D misattributes the hypotension to airway obstruction.

8. A patient received intrathecal morphine as part of her spinal for cesarean delivery to provide prolonged postoperative analgesia. Integrating the physicochemical behavior of morphine in CSF with the resulting safety requirement, what monitoring plan is appropriate and why?

A) No special monitoring is needed, because intrathecal morphine acts only at the injection segment and is fully cleared within an hour
B) Because morphine is poorly lipid-soluble, it lingers in CSF and spreads rostrally over hours, providing long analgesia but creating a risk of delayed respiratory depression; the patient requires extended respiratory monitoring (on the order of 18 to 24 hours) on a unit equipped to observe for it
C) Monitoring should focus only on the first 30 minutes, since any respiratory depression from intrathecal morphine occurs immediately or not at all
D) The patient should be monitored only for motor block, since respiratory depression does not occur with neuraxial opioids
E) Because morphine is highly lipid-soluble, it is taken up segmentally and poses no rostral-spread risk, so routine ward observation suffices

ANSWER: B

Rationale:

This links morphine's low lipid solubility to its clinical monitoring consequence. Unlike lipophilic opioids that are taken up segmentally and act quickly near the injection level, poorly lipid-soluble morphine remains in CSF and is carried rostrally over hours toward the brainstem respiratory centers, which gives prolonged analgesia but also a characteristic risk of delayed respiratory depression up to roughly 18 to 24 hours after injection. The appropriate plan is therefore extended respiratory monitoring over that window on an appropriately staffed unit. Option A wrongly treats morphine as a short, segmental agent. Option C confines monitoring to the early period, missing the delayed-depression window.

Option D: Option D ignores the real respiratory risk of neuraxial opioids.
Option E: Option E misstates morphine as highly lipid-soluble, inverting the property that drives its rostral spread and delayed risk.

9. Minutes after a large epidural dose is given, a patient becomes profoundly hypotensive and bradycardic, then dyspneic with rising sensory level and hand weakness, suggesting evolving high-to-total spinal. Integrating the mechanism of a high block with the rationale for specific resuscitative agents, which combined response is most appropriate?

A) Give phenylephrine alone, since pure alpha agonism corrects both the hypotension and the bradycardia, and defer airway management
B) Give esmolol to control the heart rate and a vasodilator to improve perfusion, with fluids for pressure
C) Withhold all drugs and simply wait, since a high spinal always resolves quickly without support
D) Support the airway and breathing (supplemental oxygen, and intubation if respiratory failure ensues), give rapid IV fluids, and use ephedrine for combined alpha and beta support when bradycardia accompanies the hypotension, adding atropine for vagally mediated bradycardia, recognizing that blockade of the T1 to T4 cardiac accelerators is driving the bradycardia
E) Treat only the blood pressure with an alpha agonist and ignore the respiratory and heart rate changes, since these are unrelated to the block

ANSWER: D

Rationale:

This integrates why a high block produces this picture with which agents address each derangement. Cephalad spread to T1 to T4 blocks the cardiac accelerator fibers, removing sympathetic drive and producing bradycardia atop the vasodilatory hypotension, while still higher spread threatens the respiratory muscles. Correct management is simultaneous: secure oxygenation and ventilation (intubating if respiratory failure develops), give rapid fluids, and choose ephedrine for its combined alpha and beta effects when bradycardia accompanies hypotension, with atropine for vagal bradycardia. Option A relies on pure alpha agonism, which does not correct and may worsen bradycardia, and dangerously defers airway care. Option B uses a beta-blocker and a vasodilator, both of which would deepen the bradycardia and hypotension. Option C is unsafe passivity in a potentially life-threatening event.

Option E: Option E ignores the linked respiratory and chronotropic consequences of a high block.

10. A patient with an indwelling epidural catheter is receiving a renally cleared anticoagulant and has chronic kidney disease (CKD) with substantially reduced creatinine clearance. Integrating the principle that anticoagulation intervals govern catheter removal as well as placement with the effect of renal function on the drug, how should removal be timed?

A) The minimum interval between the last anticoagulant dose and catheter removal should be extended beyond the standard, because reduced renal clearance in CKD prolongs the drug's effect, and removal carries hematoma risk comparable to insertion
B) The catheter may be removed at any time, because removal does not disturb epidural vessels and carries no hematoma risk
C) Only insertion timing matters; once the catheter is in place, renal function and dosing intervals are irrelevant to removal
D) The interval should be shortened in CKD, because impaired kidneys clear the drug faster and restore hemostasis sooner
E) Renal function has no bearing on the timing of any anticoagulant, so the standard interval applies unchanged

ANSWER: A

Rationale:

This combines two ideas: the timing intervals apply to catheter removal just as to placement, because withdrawing the catheter disrupts epidural vessels and carries comparable hematoma risk; and renal impairment prolongs the effect of a renally cleared anticoagulant, so its residual activity persists longer. The safe interval before removal must therefore be lengthened beyond the standard in CKD. Option B is dangerous because catheter removal does carry hematoma risk. Option C wrongly exempts removal from interval and renal considerations. Option E denies the established influence of renal function on anticoagulant duration.

Option D: Option D inverts renal pharmacokinetics; reduced clearance prolongs, not shortens, drug effect.

11. A postoperative patient with a thoracic epidural infusion develops progressive lower-extremity weakness. You reduce the infusion, but over the next two hours the weakness worsens; the patient is afebrile and was anticoagulated perioperatively. Integrating the motor-block workup algorithm with the discrimination between hematoma and abscess, what is the correct interpretation and action?

A) Continue reducing the infusion and reassess in the morning, since all motor weakness during an epidural is pharmacologic
B) Diagnose epidural abscess and start antibiotics, since any neurologic deficit with a catheter indicates infection
C) Recognize that weakness progressing despite infusion reduction is not pharmacologic, and that the rapid (hours) course in an anticoagulated, afebrile patient fits epidural hematoma rather than abscess; obtain urgent spine MRI and arrange emergent neurosurgical decompression
D) Increase the infusion to confirm the block is pharmacologic before ordering any imaging
E) Remove the catheter immediately without regard to anticoagulant timing, then observe

ANSWER: C

Rationale:

This requires applying the workup logic and then the differential. The first step (reduce or stop the infusion) has already been taken; weakness that progresses despite that step is, by the algorithm, no longer attributable to pharmacologic over-blockade and demands urgent imaging. Layering the hematoma-versus-abscess discrimination, the rapid evolution over hours in an anticoagulated, afebrile patient fits epidural hematoma rather than the slower, febrile course of abscess. The correct action is urgent spine MRI and emergent neurosurgical decompression. Option A dangerously normalizes a progressing deficit. Option B misassigns the picture to abscess and substitutes antibiotics for the needed surgical decompression. Option D would deepen the block and waste critical time.

Option E: Option E ignores anticoagulant timing at removal and does not address the cord compression requiring decompression.

12. A patient with severe cardiac disease whose hemodynamics tolerate only gradual changes needs lower-extremity surgery under neuraxial anesthesia. Integrating the mechanics of the combined spinal-epidural (CSE) technique with the hemodynamic danger of an abrupt sympathectomy, why might CSE be preferred over a single-shot spinal, and how is it used here?

A) CSE is preferred because it delivers a larger single intrathecal dose than a standard spinal, producing the block faster
B) CSE offers no hemodynamic advantage and is chosen only for its speed of needle placement
C) A single-shot spinal at full dose is always safer in cardiac disease because it avoids any catheter
D) CSE is preferred because it eliminates sympathetic blockade entirely, so no hypotension can occur
E) CSE allows a deliberately low initial intrathecal dose (below that needed for reliable solo spinal anesthesia) to be supplemented through the epidural catheter in titrated increments, reaching the target block level gradually and blunting the rapid profound sympathectomy and hypotension that a full single-shot spinal dose would impose on a preload-dependent heart

ANSWER: E

Rationale:

This integrates how CSE works with why gradual block matters in fragile cardiac physiology. By giving a low intrathecal dose, intentionally below the amount needed for reliable solo spinal anesthesia, and then titrating epidural supplementation to reach the target level, the clinician builds the block incrementally rather than imposing the rapid, profound sympathectomy of a full single-shot spinal. The gradual onset limits the abrupt vasodilation and preload loss that a preload-dependent, severely diseased heart tolerates poorly. Option B denies the hemodynamic benefit that is the whole point here. Option C wrongly claims a full single-shot spinal is safer, when its abrupt sympathectomy is exactly the hazard.

Option A: Option A misstates CSE as delivering a larger single intrathecal dose; its advantage is the opposite, a smaller initial dose.
Option D: Option D is incorrect because CSE does not abolish sympathetic blockade; it makes its onset more gradual and controllable.

13. A low-body-weight patient with compensated hepatic disease is being discharged home with an ambulatory continuous peripheral nerve block (CPNB) infusion for several days. Integrating the pharmacokinetics of prolonged local anesthetic infusion with this patient's specific risk factors, how should you set the infusion and counsel the patient?

A) Use a standard infusion rate unchanged, since accumulation does not occur with peripheral catheters regardless of patient factors
B) Recognize that prolonged infusion can lead to drug accumulation and that hepatic impairment and low body weight raise plasma levels for a given rate, so use a reduced infusion rate (favoring ropivacaine for its wider cardiac safety margin) and counsel the patient and caregivers to recognize early local anesthetic systemic toxicity (LAST) symptoms such as perioral numbness, tinnitus, and metallic taste, along with fall precautions
C) Increase the infusion rate to compensate for the small body size, since smaller patients clear drug faster
D) Choose bupivacaine specifically because its narrower cardiac safety margin is advantageous during long infusions
E) Reassure the patient that systemic toxicity cannot occur once the catheter is outside the neuraxis, so no symptom education is needed

ANSWER: B

Rationale:

This integrates accumulation kinetics with patient-specific risk. Over a multi-day infusion, local anesthetic can accumulate, and hepatic impairment (reduced metabolism) and low body weight (smaller volume of distribution) both raise plasma concentrations for any given rate, narrowing the safety margin. The appropriate response is to reduce the infusion rate, favor ropivacaine for its wider cardiac safety margin, and educate the patient and caregivers to recognize early LAST symptoms (perioral numbness, tinnitus, metallic taste) and to observe fall precautions from motor block. Option A wrongly denies accumulation and the relevance of patient factors. Option D selects the agent with the narrower safety margin and misframes that as an advantage. Option E falsely reassures; systemic toxicity from absorbed drug is precisely the risk that mandates symptom education.

Option C: Option C inverts the pharmacokinetics; small, hepatically impaired patients clear drug more slowly, not faster.